Cite
Goldacre B, Lane S, Mahtani KR, et al. Pharmaceutical companies' policies on access to trial data, results, and methods: audit study. BMJ. 2017;358:j3334doi: 10.1136/bmj.j3334.
Goldacre, B., Lane, S., Mahtani, K. R., Heneghan, C., Onakpoya, I., Bushfield, I., & Smeeth, L. (2017). Pharmaceutical companies' policies on access to trial data, results, and methods: audit study. BMJ (Clinical research ed.), 358j3334. https://doi.org/10.1136/bmj.j3334
Goldacre, Ben, et al. "Pharmaceutical companies' policies on access to trial data, results, and methods: audit study." BMJ (Clinical research ed.) vol. 358 (2017): j3334. doi: https://doi.org/10.1136/bmj.j3334
Goldacre B, Lane S, Mahtani KR, Heneghan C, Onakpoya I, Bushfield I, Smeeth L. Pharmaceutical companies' policies on access to trial data, results, and methods: audit study. BMJ. 2017 Jul 26;358:j3334. doi: 10.1136/bmj.j3334. PMID: 28747301.
Copy
Download .nbib